ANAB Stock Summary and Trading Ideas (Anaptysbio | NASDAQ:ANAB)

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Anaptysbio trades on the NASDAQ stock market under the symbol ANAB.

As of February 28, 2025, ANAB stock price climbed to $16.82 with 853,728 million shares trading.

ANAB has a beta of 2.62, meaning it tends to be more sensitive to market movements. ANAB has a correlation of 0.12 to the broad based SPY ETF.

ANAB has a market cap of $511.81 million. This is considered a Small Cap stock.

Last quarter Anaptysbio reported $43 million in Revenue and -$.72 earnings per share. This beat revenue expectation by $33 million and exceeded earnings estimates by $1.02.

In the last 3 years, ANAB traded as high as $41.31 and as low as $12.21.

The top ETF exchange traded funds that ANAB belongs to (by Net Assets): XBI, VTI, IWM, VXF, VB.

ANAB has underperformed the market in the last year with a price return of -36.5% while the SPY ETF gained +18.6%. ANAB has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -33.0% and -12.8%, respectively, while the SPY returned -0.4% and -2.6%, respectively.

ANAB support price is $15.34 and resistance is $17.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANAB shares will trade within this expected range on the day.